PHA6PS26HKI Pharmacotherapy and medical calculations for children and adolescents (2op)
Toteutuksen tunnus: PHA6002N24S-3001
Toteutuksen perustiedot
- Ilmoittautumisaika
- 07.01.2026 - 03.05.2026
- Ilmoittautuminen toteutukselle ei ole vielä alkanut.
- Ajoitus
- 01.08.2026 - 31.12.2026
- Toteutus ei ole vielä alkanut.
- Opintopistemäärä
- 2 op
- Lähiosuus
- 2 op
- Toteutustapa
- Lähiopetus
- Yksikkö
- Terveys- ja kirkonala
- Kampus
- Helsinki
- Opetuskielet
- englanti
- Paikat
- 0 - 100
- Koulutus
- Degree Programme in Health Care, Nursing
Toteutukselle PHA6PS26HKI Pharmacotherapy and medical calculations for children and adolescents PHA6002N24S-3001 ei valitettavasti löytynyt varauksia. Varauksia ei ole mahdollisesti vielä julkaistu tai toteutus on itsenäisesti suoritettava.
Arviointiasteikko
0-5
Tavoitteet
Students
• understand the principles of pharmacotherapy of the most common child and adolescent diseases and know how to apply the information in nursing
• understand the specificities of pharmacotherapy for children and adolescents of different ages
• can safely administer medicines and fluids to children and adolescents using different routes of administration
• can offer guidance on pharmacotherapy and its self-monitoring to children and adolescents and their families
• can plan, implement and evaluate medical and non-medical pain management for children and adolescents of different ages
• can perform the medical calculations included in the course
Sisältö
• drug and medication safety
• the specificities of patient safety in pharmacotherapy in the treatment of children and adolescents
• the most common active ingredient groups and their effects, side effects, combined actions and mechanisms of action for children and adolescents
• treatment of pain for children and adolescents
• guidance on the implementation and self-monitoring of pharmacotherapy for children and adolescents and ensuring their commitment to it
• medical calculations
Esitietovaatimukset
Safe pharmacotherapy and medical calculation (PHA1) and Adult pharmacotherapy and medical calculation (PHA2) must be completed.